RIGHTFund

2021년 July 30일

RIGHT Fund commits additional 13.6 billion KRW to innovative infectious disease R&D projects

  RIGHT Fund (CEO Younbeen Kim / Research Investment for Global Health Technology Fund) has announced its selection of 2021 research grant award recipients for an […]
2021년 June 28일

Column: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Elevating Korea’s Global Contribution in the Midst of the Pandemic”

Published in Hankook Ilbo This article is only available in Korean. Original Article  
2021년 February 26일

Taking equal accessibility and virus variants into consideration in prioritizing vaccine R&D

Publication only available in Korean. Original Article  
2021년 February 22일

BioIN_ Global PPP Infectious Disease R&D Platform Based in South Korea